{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/23/3315982/0/en/Silexion-Therapeutics-Receives-Approval-from-Germany-s-BfArM-to-Initiate-Phase-2-3-Clinical-Trial-of-SIL204-in-Locally-Advanced-Pancreatic-Cancer.html", "message": "News view counter 811645 successfully enlarged"}